Metabolic dysfunction associated steatotic liver disease (MASLD) is a liver condition often linked with obesity and diabetes, especially in kids. The study is testing a new way to spot this liver issue using a special ultrasound called Velacur. Unlike traditional liver biopsies, which involve a needle and can be painful, Velacur is non-invasive, meaning it doesn't need to break the skin. It gives quick results about liver fat and hardness, helping doctors see how healthy the liver is.

MRI is currently the best non-invasive tool but is expensive and not always available. Velacur offers a simpler and cheaper option, suitable for clinics and easy to use. The study compares Velacur with MRI and liver biopsies to see how well it works. Kids aged 2-20 suspected of having MASLD can join the study, but they can't participate if they have certain conditions like ascites, are pregnant, or have devices like pacemakers.

• Study involves a simple ultrasound test.
• Participants must be 2-20 years old with suspected liver issues.
• Parental consent is necessary for participation.